Blog

Medicare Proposes Reimbursement Rate Increase for HIFU Prostate Treatments

Published:
The US Centers for Medicare and Medicaid Services has proposed a rule that – if approved – would increase the reimbursement that treatment sites receive for performing focused ultrasound for the prostate. Two HIFU manufacturers – EDAP and Sonablate Corp. – publicly support the proposed rule. The comment period closes in September, and the Foundation encourages those in the field to voice their support.
Read More ...

Insightec to Begin Comparative Prostate Cancer Trial

Published:
The US FDA has granted an investigational device exemption (IDE) for Insightec to begin a clinical trial comparing its focused ultrasound device to active surveillance in patients with prostate cancer. The Exablate Prostate system uses focused ultrasound to ablate target tissue under MRI guidance. An earlier clinical trial using the device showed positive results with minimal complications.
Read More ...

Meeting Report: Society of Interventional Radiology (SIR) 2022

Published:
SIR held its 2022 Annual Meeting in Boston from June 11–16. There were seven scientific presentations on focused ultrasound, and two manufacturers in the field participated. A Foundation-sponsored reception and several educational sessions throughout the meeting focused on cultivating the next generation of interventional radiologists.
Read More ...
Company Profile: Advanced Microbubbles, Inc. Focused Ultrasound Liver Tumor Treatment Receives CMS Reimbursement Meeting Report: Congress of Neurological Surgeons (CNS) Annual Meeting